Molbio Diagnostics Limited: insider trading, SAST and pledges

No insider-trading filing for this company in the last two years.

FiledAcquirerDirectionModeAcquiredSoldHolding afterPromoter
1 Oct 2026India Business Excellence Fund III, a scheme of Business Excellence Trust III
Reg29(2)
Sale Open Market — 3,000,000
2.60%
8.92% No
30 Sep 2026India Business Excellence Fund III, a scheme of Business Excellence Trust III
Reg29(2)
Sale Open Market — 3,000,000
2.60%
8.92% No
30 Sep 2026India Business Excellence Fund III
Reg29(2)
Sale Open Market — 3,000,000
2.60%
8.92% No
Page 1 of 1

Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.